James D Chalmers (@profjdchalmers) 's Twitter Profile
James D Chalmers

@profjdchalmers

Asthma and Lung UK Chair of Respiratory Research, University of Dundee. Chief Editor of the European Respiratory Journal. Tweets in a personal capacity

ID: 1155952820966703105

calendar_today29-07-2019 21:26:43

5,5K Tweet

8,8K Followers

2,2K Following

American Thoracic Society (ATS) (@atscommunity) 's Twitter Profile Photo

šŸ“… Experts will discuss whether clinical trials should change course and begin grouping patients with cystic fibrosis and non-cystic fibrosis bronchiectasis during a must-see Tuesday session at #ATS2025. šŸ”— Read more in ATS Conference News: atsconferencenews.org/ats-journals-s…

šŸ“… Experts will discuss whether clinical trials should change course and begin grouping patients with cystic fibrosis and non-cystic fibrosis bronchiectasis during a must-see Tuesday session at #ATS2025. 

šŸ”— Read more in ATS Conference News: atsconferencenews.org/ats-journals-s…
James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

Asthma and Lung UK gave me a 5 year grant in 2017 that allowed us to study the idea that personalised anti-inflammatory treatment would be the way to treat bronchiectasis in future It changed my career and the careers of several young scientists I could not be more grateful šŸ™šŸ™

James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

On international clinical trials day we say thank you to all of the patients participating in bronchiectasis research to find new treatments and understand more about the disease #bronchiectasis EMBARC Stefano Aliberti Merete Long Holly Lind Dr. Kateryna Viligorska European Lung Foundation

James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

Thrilled to announce exciting results of the Great2 trial of a monoclonal antibody against Pseudomonas in bronchiectasis - reduce bacterial load at day 84 - significant improvement in quality of life - reduced exacerbations Merete Long EMBARC bronchiectasis.net/clinical-trial…

Thrilled to announce exciting results of the Great2 trial of a monoclonal antibody against Pseudomonas in bronchiectasis 
- reduce bacterial load at day 84
- significant improvement in quality of life
- reduced exacerbations 
<a href="/MereteLong/">Merete Long</a> <a href="/EMBARCnetwork/">EMBARC</a> 
bronchiectasis.net/clinical-trial…
Merete Long (@meretelong) 's Twitter Profile Photo

Truly honored to receive this award- I’m deeply grateful to work with such an incredible and supportive team on research that makes a real difference. Thank you!

CHESTĀ® Journal (@journal_chest) 's Twitter Profile Photo

Can the serum antiglycopeptidolipid core IgA antibody test be used to screen for nontuberculous mycobacterial pulmonary disease in #bronchiectasis? Read the full research in the May issue of the journal CHESTĀ®: hubs.la/Q03ndp100 #MedEd #JournalCHEST #NTMPD

Can the serum antiglycopeptidolipid core IgA antibody test be used to screen for nontuberculous mycobacterial pulmonary disease in #bronchiectasis?

Read the full research in the May issue of the journal CHESTĀ®: hubs.la/Q03ndp100
#MedEd #JournalCHEST #NTMPD
American Thoracic Society (ATS) (@atscommunity) 's Twitter Profile Photo

Key updates on CAP treatment guidelines will be unveiled Tuesday at #ATS2025! šŸ“… Don't miss the session, "ATS Guidelines: Controversies in the Management of CAP and ARDS." šŸ”— Learn more in ATS Conference News: atsconferencenews.org/experts-to-unv…

Key updates on CAP treatment guidelines will be unveiled Tuesday at #ATS2025!

šŸ“… Don't miss the session, "ATS Guidelines: Controversies in the Management of CAP and ARDS."

šŸ”— Learn more in ATS Conference News: atsconferencenews.org/experts-to-unv…
James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

Squeezing in one last session before the end of American Thoracic Society (ATS) Post infection complications including of course BRONCHIECTASIS! Following on from our ATS statement led by Sara Auld and Scott Evans

Squeezing in one last session before the end of <a href="/atscommunity/">American Thoracic Society (ATS)</a> 
Post infection complications including of course 
BRONCHIECTASIS!
Following on from our ATS statement led by Sara Auld and Scott Evans
Jen A-Brett (@jablab3) 's Twitter Profile Photo

My šŸ™ to Ajay Sheshadri, Sara Auld and Scott Evans for organizing and the other speakers James D Chalmers Yael Aschner and Assem Ziady for this awesome PIPC session to close #ATS2025

My šŸ™ to <a href="/ajaysheshadri/">Ajay Sheshadri</a>, Sara Auld and Scott Evans for organizing and the other speakers <a href="/ProfJDChalmers/">James D Chalmers</a> Yael Aschner and Assem Ziady for this awesome PIPC session to close #ATS2025
American Thoracic Society (ATS) (@atscommunity) 's Twitter Profile Photo

That's a wrap! Thank you attendees, presenters, exhibitors, and supporters for joining us for #ATS2025. We hope you made long-lasting connections and leave feeling inspired by the latest scientific breakthroughs in pulmonary, critical care, and sleep medicine. Excited for

That's a wrap! Thank you attendees, presenters, exhibitors, and supporters for joining us for #ATS2025.

We hope you made long-lasting connections and leave feeling inspired by the latest scientific breakthroughs in pulmonary, critical care, and sleep medicine.

Excited for
HCPLive (@hcplivenews) 's Twitter Profile Photo

New at #ATS2025: Findings on brensocatib for non-cystic fibrosis bronchiectasis showed consistent efficacy as well as safety across 3 subgroups of patients. James D Chalmers gave several valuable insights on his team's data in the ASPEN trial. View šŸ‘‡ šŸ”—hcplive.com/view/subgroup-…

James D Chalmers (@profjdchalmers) 's Twitter Profile Photo

And that’s a wrap for a great ATS conference Highlights including a paradigm shifting discussion on bringing bronchiectasis and CF together as well as presentations by the brilliant Merete Long See you in Orlando next year!

And that’s a wrap for a great ATS conference 
Highlights including a paradigm shifting discussion on bringing bronchiectasis and CF together as well as presentations by the brilliant <a href="/MereteLong/">Merete Long</a> 
See you in Orlando next year!